/PRNewswire/ The Board of Directors of Karo Pharma Aktiebolag ("Karo Pharma" or the "Company") has resolved to apply for de-listing of the Company s shares.
On August 16, 2022, the shares in Karo Pharma Aktiebolag (the "Company") were
given observation status with reference to a public takeover offer from Karo
Intressenter AB to the other shareholders in the
/PRNewswire/ Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma" or the.
STOCKHOLM, Sept. 26, 2022 /PRNewswire/ Karo Intressenter AB[1] ("Karo Intressenter") announced a public cash offer to the shareholders in Karo Pharma Aktiebolag ("Karo Pharma" or the "Company")